N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide

C202H199F5N34O10 — CID 165024967

IUPACN-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide
SMILESCc1cccc(C(CN)NC(=O)c2cc(C#N)cc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cc(CN3CCCC3)cc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1F.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1
InChIInChI=1S/C28H30FN5O.C28H31N5O.C27H28FN5O.C25H23N5O.C24H23FN4O.C24H23N3O2.C23H21FN4O.C23H20FN3O2/c1-18-5-4-6-21(11-18)26(16-30)31-28(35)23-13-19(17-34-9-2-3-10-34)12-22(14-23)20-7-8-25-24(15-20)27(29)33-32-25;1-19-5-3-7-23(15-19)27(18-33-13-11-29-12-14-33)30-28(34)24-8-4-6-21(16-24)22-9-10-26-25(17-22)20(2)31-32-26;1-18-4-2-6-21(14-18)25(17-33-12-10-29-11-13-33)30-27(34)22-7-3-5-19(15-22)20-8-9-24-23(16-20)26(28)32-31-24;1-15-4-3-5-19(8-15)24(14-27)28-25(31)21-10-17(13-26)9-20(11-21)18-6-7-23-22(12-18)16(2)29-30-23;1-14-5-3-8-19(23(14)25)22(13-26)27-24(30)18-7-4-6-16(11-18)17-9-10-21-20(12-17)15(2)28-29-21;1-15-5-3-7-19(11-15)23(14-28)25-24(29)20-8-4-6-17(12-20)18-9-10-22-21(13-18)16(2)26-27-22;1-14-4-2-6-17(10-14)21(13-25)26-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)28-27-20;1-14-4-2-6-17(10-14)21(13-28)25-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)27-26-20/h4-8,11-15,26H,2-3,9-10,16-17,30H2,1H3,(H,31,35)(H,32,33);3-10,15-17,27,29H,11-14,18H2,1-2H3,(H,30,34)(H,31,32);2-9,14-16,25,29H,10-13,17H2,1H3,(H,30,34)(H,31,32);3-12,24H,14,27H2,1-2H3,(H,28,31)(H,29,30);3-12,22H,13,26H2,1-2H3,(H,27,30)(H,28,29);3-13,23,28H,14H2,1-2H3,(H,25,29)(H,26,27);2-12,21H,13,25H2,1H3,(H,26,29)(H,27,28);2-12,21,28H,13H2,1H3,(H,25,29)(H,26,27)
InChIKeyLSTGXGRFWHTYPR-UHFFFAOYSA-N
MW3358.03 g/mol
LogP34.10
Rot. Bonds44

About N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide

N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide (PubChem CID 165024967) has the molecular formula C202H199F5N34O10 and a molecular weight of 3358.03 g/mol. Its IUPAC name is N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide.

Molecular Properties

Compound NameN-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide
PubChem CID165024967
Molecular FormulaC202H199F5N34O10
Molecular Weight3358.03 g/mol
Exact Mass3355.60
IUPAC NameN-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide
SMILESCc1cccc(C(CN)NC(=O)c2cc(C#N)cc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cc(CN3CCCC3)cc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1F.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1
InChIInChI=1S/C28H30FN5O.C28H31N5O.C27H28FN5O.C25H23N5O.C24H23FN4O.C24H23N3O2.C23H21FN4O.C23H20FN3O2/c1-18-5-4-6-21(11-18)26(16-30)31-28(35)23-13-19(17-34-9-2-3-10-34)12-22(14-23)20-7-8-25-24(15-20)27(29)33-32-25;1-19-5-3-7-23(15-19)27(18-33-13-11-29-12-14-33)30-28(34)24-8-4-6-21(16-24)22-9-10-26-25(17-22)20(2)31-32-26;1-18-4-2-6-21(14-18)25(17-33-12-10-29-11-13-33)30-27(34)22-7-3-5-19(15-22)20-8-9-24-23(16-20)26(28)32-31-24;1-15-4-3-5-19(8-15)24(14-27)28-25(31)21-10-17(13-26)9-20(11-21)18-6-7-23-22(12-18)16(2)29-30-23;1-14-5-3-8-19(23(14)25)22(13-26)27-24(30)18-7-4-6-16(11-18)17-9-10-21-20(12-17)15(2)28-29-21;1-15-5-3-7-19(11-15)23(14-28)25-24(29)20-8-4-6-17(12-20)18-9-10-22-21(13-18)16(2)26-27-22;1-14-4-2-6-17(10-14)21(13-25)26-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)28-27-20;1-14-4-2-6-17(10-14)21(13-28)25-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)27-26-20/h4-8,11-15,26H,2-3,9-10,16-17,30H2,1H3,(H,31,35)(H,32,33);3-10,15-17,27,29H,11-14,18H2,1-2H3,(H,30,34)(H,31,32);2-9,14-16,25,29H,10-13,17H2,1H3,(H,30,34)(H,31,32);3-12,24H,14,27H2,1-2H3,(H,28,31)(H,29,30);3-12,22H,13,26H2,1-2H3,(H,27,30)(H,28,29);3-13,23,28H,14H2,1-2H3,(H,25,29)(H,26,27);2-12,21H,13,25H2,1H3,(H,26,29)(H,27,28);2-12,21,28H,13H2,1H3,(H,25,29)(H,26,27)
InChIKeyLSTGXGRFWHTYPR-UHFFFAOYSA-N
XLogP34.10
TPSA664.35 Ų
H-Bond Donors24
H-Bond Acceptors28
Rotatable Bonds44
Heavy Atoms251
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003358.03
LogP ≤ 534.10
H-Bond Donors ≤ 524
H-Bond Acceptors ≤ 1028

Analyze N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide?
The IUPAC name of N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide (CID 165024967) is N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide.
What is the SMILES notation for N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide?
The canonical SMILES for N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide is Cc1cccc(C(CN)NC(=O)c2cc(C#N)cc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cc(CN3CCCC3)cc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1F.Cc1cccc(C(CN)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CN2CCNCC2)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(C)c4c3)c2)c1.Cc1cccc(C(CO)NC(=O)c2cccc(-c3ccc4n[nH]c(F)c4c3)c2)c1.
What is the InChIKey of N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide?
The InChIKey is LSTGXGRFWHTYPR-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H30FN5O.C28H31N5O.C27H28FN5O.C25H23N5O.C24H23FN4O.C24H23N3O2.C23H21FN4O.C23H20FN3O2/c1-18-5-4-6-21(11-18)26(16-30)31-28(35)23-13-19(17-34-9-2-3-10-34)12-22(14-23)20-7-8-25-24(15-20)27(29)33-32-25;1-19-5-3-7-23(15-19)27(18-33-13-11-29-12-14-33)30-28(34)24-8-4-6-21(16-24)22-9-10-26-25(17-22)20(2)31-32-26;1-18-4-2-6-21(14-18)25(17-33-12-10-29-11-13-33)30-27(34)22-7-3-5-19(15-22)20-8-9-24-23(16-20)26(28)32-31-24;1-15-4-3-5-19(8-15)24(14-27)28-25(31)21-10-17(13-26)9-20(11-21)18-6-7-23-22(12-18)16(2)29-30-23;1-14-5-3-8-19(23(14)25)22(13-26)27-24(30)18-7-4-6-16(11-18)17-9-10-21-20(12-17)15(2)28-29-21;1-15-5-3-7-19(11-15)23(14-28)25-24(29)20-8-4-6-17(12-20)18-9-10-22-21(13-18)16(2)26-27-22;1-14-4-2-6-17(10-14)21(13-25)26-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)28-27-20;1-14-4-2-6-17(10-14)21(13-28)25-23(29)18-7-3-5-15(11-18)16-8-9-20-19(12-16)22(24)27-26-20/h4-8,11-15,26H,2-3,9-10,16-17,30H2,1H3,(H,31,35)(H,32,33);3-10,15-17,27,29H,11-14,18H2,1-2H3,(H,30,34)(H,31,32);2-9,14-16,25,29H,10-13,17H2,1H3,(H,30,34)(H,31,32);3-12,24H,14,27H2,1-2H3,(H,28,31)(H,29,30);3-12,22H,13,26H2,1-2H3,(H,27,30)(H,28,29);3-13,23,28H,14H2,1-2H3,(H,25,29)(H,26,27);2-12,21H,13,25H2,1H3,(H,26,29)(H,27,28);2-12,21,28H,13H2,1H3,(H,25,29)(H,26,27).
What are the key properties of N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide?
N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide has a molecular weight of 3358.03 g/mol, XLogP of 34.10, 44 rotatable bonds, 24 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-amino-1-(2-fluoro-3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-cyano-5-(3-methyl-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)benzamide;N-[2-amino-1-(3-methylphenyl)ethyl]-3-(3-fluoro-2H-indazol-5-yl)-5-(pyrrolidin-1-ylmethyl)benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[2-hydroxy-1-(3-methylphenyl)ethyl]benzamide;3-(3-fluoro-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide;N-[2-hydroxy-1-(3-methylphenyl)ethyl]-3-(3-methyl-2H-indazol-5-yl)benzamide;3-(3-methyl-2H-indazol-5-yl)-N-[1-(3-methylphenyl)-2-piperazin-1-ylethyl]benzamide is sourced from PubChem (CID 165024967), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).